Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

14 trials with published results (11%)

Research Maturity

99 completed trials (76% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 60/100

Termination Rate

11.5%

15 terminated out of 130 trials

Success Rate

86.8%

+0.3% vs benchmark

Late-Stage Pipeline

6%

8 trials in Phase 3/4

Results Transparency

14%

14 of 99 completed with results

Key Signals

14 with results87% success15 terminated

Data Visualizations

Phase Distribution

115Total
Not Applicable (16)
P 1 (72)
P 2 (19)
P 3 (8)

Trial Status

Completed99
Terminated15
Unknown8
Withdrawn7
Recruiting1

Trial Success Rate

86.8%

Benchmark: 86.5%

Based on 99 completed trials

Clinical Trials (130)

Showing 20 of 20 trials
NCT00900471Recruiting

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

NCT00638898Phase 1Completed

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

NCT01586104Not ApplicableCompleted

Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

NCT04525014Phase 1Terminated

RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors

NCT00138216Phase 1Completed

Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

NCT00788125Phase 1Terminated

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

NCT00900120Withdrawn

Collecting and Storing Blood Samples From Patients With Cancer

NCT01346267Not ApplicableCompleted

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy

NCT00003816Phase 2Completed

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

NCT00536601Not ApplicableCompleted

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00608933Phase 3Completed

Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine

NCT01987596Phase 3Terminated

Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer

NCT00673257Not ApplicableCompletedPrimary

Pharmacokinetics of Daunorubicin in Young Patients With Cancer

NCT01557881Not ApplicableTerminated

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

NCT00985868Phase 1CompletedPrimary

AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors

NCT01305200Phase 3Completed

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

NCT01791088Phase 1Completed

Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

NCT00258180Phase 2Completed

Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy

NCT00003194Phase 1TerminatedPrimary

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

NCT00296049Not ApplicableWithdrawn

Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy

Scroll to load more

Research Network

Activity Timeline